V1RC15 inhibitors constitute a class of chemical compounds designed to selectively interact with a particular biological target, typically a protein or enzyme, which is identified by the code V1RC15. The function of inhibitors in general is to bind to their targets with high specificity and affinity, which results in the modulation of the activity of the target. By doing so, they can alter the conformation, functionality, or stability of the target molecule, often leading to a decrease in its activity or an alteration in its interaction with other molecules within a biological system.
The design of V1RC15 inhibitors typically involves a thorough understanding of the molecular structure of the V1RC15 target. This could include knowledge about the active sites, binding pockets, or allosteric sites on the protein that are crucial for its function. Using techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy, scientists are able to determine the three-dimensional arrangement of atoms within the target and thus identify potential sites for inhibitor binding. Chemical inhibitors are then crafted through a combination of medicinal chemistry, computational modeling, and iterative synthesis to achieve a molecule that fits snugly into the target site. This "lock-and-key" interaction is fundamental to the inhibitor's ability to modulate the target's activity. The compounds may also be optimized for desirable pharmacokinetic properties, ensuring that they are stable and can reach their target in the biological context for which they are designed. The development of V1RC15 inhibitors typically requires a multi-disciplinary approach involving chemistry, biology, and computational science.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
An EGFR inhibitor that may impact V1RC15 activity by hindering downstream signaling pathways that V1RC15 might be a part of. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Similar to Erlotinib, it is an EGFR inhibitor that could indirectly decrease V1RC15 activity if V1RC15 functions downstream of EGFR. | ||||||